Autopsy report · NCT00444808

Analgesic Effect of Intranasal Calcitonin on Patients With Fractured Ribs

“Medication expired”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 11 months before it stopped.
• 19 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Université de Montréal

Sponsor type

University, hospital or other

Conditions

Rib Fractures; Pain

Interventions

Intranasal calcitonin

Participants

19

Sites

1

Countries

Canada

Trials that died the same way

• Effect of Chitosan-N-Acetylcysteine on IOL-power Prior to Cataract Surgery
  “Medical device expired” (69% match in meaning)
• Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy
  “Study drug expiry date not extended” (64% match in meaning)
• Phase I Study of CS-7017 and Bexarotene
  “Drug no longer available” (64% match in meaning)
• Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer
  “Drug was no longer available” (63% match in meaning)
• Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer
  “Drug expired and access to additional supply ended. PI left the institution shortly afterwards and the study will not be re-activated. Only 4 patients were enrolled.” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.